How Tuberculosis Causes SIADH
Tuberculosis causes SIADH through ectopic production of antidiuretic hormone (ADH/vasopressin) by infected lung tissue and/or through a "reset osmostat" mechanism where the normal osmotic threshold for ADH secretion is inappropriately lowered.
Primary Mechanisms
The pathophysiology of TB-associated SIADH involves two main mechanisms:
Ectopic ADH Production
Direct evidence demonstrates that tuberculous lung tissue can produce ADH ectopically 1. In documented cases, patients with pulmonary TB and hyponatremia show detectable circulating vasopressin levels despite hypo-osmolality—a hallmark of inappropriate ADH secretion 2. This represents autonomous hormone production independent of normal osmotic regulation.
Reset Osmostat Phenomenon
A larger study of 28 hyponatremic TB patients revealed that plasma vasopressin remains detectable despite low serum osmolality but does respond to further osmotic changes 2. When given water loads, these patients showed:
- Decline in vasopressin levels (from 1.85 ± 1.32 to 0.77 ± 0.25 pg/mL)
- Partial improvement in water excretion
- Variable impairment in diluting ability
This suggests the osmoregulatory set point is abnormally low rather than completely autonomous, explaining why some patients show partial responses to interventions 2.
Clinical Spectrum and Severity
SIADH can occur even with mild pulmonary TB involvement, contrary to earlier assumptions that extensive disease was required 3. A documented case showed status epilepticus from severe hyponatremia in a patient with only mild radiographic lung involvement 3. This underscores that the degree of lung disease does not predict SIADH severity.
The hyponatremia typically resolves within days to weeks of initiating antituberculous therapy 2, supporting that active TB infection drives the inappropriate ADH secretion.
Important Distinction: SIADH vs Cerebral Salt Wasting
In tuberculous meningitis specifically, cerebral salt wasting (CSW) is actually more common than SIADH 4. This distinction is critical because:
- CSW requires volume expansion with saline and salt supplementation
- SIADH requires fluid restriction (though this has not proven beneficial in TBM and should be avoided 4)
- Treating one condition as the other can be detrimental
Key differentiating features:
- CSW: Hypovolemia, dehydration, polyuria, negative fluid balance, weight loss
- SIADH: Euvolemia or hypervolemia, concentrated urine despite hyponatremia
Clinical Implications
Pulmonary TB
For pulmonary TB with SIADH, the mechanism is primarily ectopic ADH production with possible reset osmostat contribution. Treatment focuses on:
- Initiating antituberculous therapy (definitive treatment)
- Fluid restriction for mild-moderate cases
- Hypertonic saline (3%) for severe symptomatic hyponatremia with seizures or coma 4
Tuberculous Meningitis
For TBM-associated hyponatremia, assume CSW until proven otherwise given its higher prevalence 4. Volume assessment is essential before restricting fluids, as volume contraction may contribute to border zone infarctions in TBM 4.
Common Pitfall
Do not automatically restrict fluids in all TB patients with hyponatremia—determine the underlying mechanism first. In TBM, fluid restriction can worsen outcomes 4.
The resolution of hyponatremia with antituberculous treatment confirms that active mycobacterial infection drives the hormonal dysregulation, whether through direct ectopic production or inflammatory-mediated osmostat resetting 2.